NCT05123118

Brief Summary

This pilot clinical trial aims to integrate maternal smoking cessation and breastfeeding interventions to enhance both cancer prevention behaviors. The investigators will recruit 40 daily smoking women in their early pregnancy and randomize them into the integrated intervention or control group. Main outcomes include smoking abstinence and breastfeeding rates at 6 months postpartum.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

October 26, 2021

Completed
22 days until next milestone

First Posted

Study publicly available on registry

November 17, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2023

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

April 17, 2025

Completed
Last Updated

April 17, 2025

Status Verified

April 1, 2025

Enrollment Period

2.8 years

First QC Date

October 26, 2021

Results QC Date

March 17, 2025

Last Update Submit

April 11, 2025

Conditions

Keywords

PregnancyPostpartumSmoking abstinenceBreastfeeding intentionBreastfeeding duration

Outcome Measures

Primary Outcomes (3)

  • Number of Participants With Smoking Abstinence

    Based on their recorded daily numbers of cigarettes and cigars smoked after enrollment, the investigators will classify smoking abstinence status in the past 7 days (7-day point-prevalence). The self-reported smoking abstinence will be biochemically confirmed by urine cotinine tests (\<50 ng/mL).

    6 months postpartum

  • Number of Participants With Reported Intent to Breastfeed

    During pregnancy, participants will report breastfeeding intention using questionnaires modified from the Infant Feeding Practices Study II. The question is, "What method do you plan to use to feed your new baby in the first few weeks?" with 4 response options: 1) breastfeeding only (baby will not be given formula), 2) formula feed only, 3) both breastfeed and formula feed, or 4) unsure. We create a binary variable to indicate breastfeeding intentions (option 1 or 3) or other feeding intentions (option 2 or 4).

    35 weeks of pregnancy (the end of pregnancy)

  • Number of Participants Reporting to Breastfeed

    During postpartum, mothers report their breastfeeding status (exclusive, mixed with formula, non-breastfeeding) every month until 6 months postpartum. Any breastfeeding is defined as exclusive breastfeeding or mixed-feeding breast milk and formula.

    6 months postpartum

Study Arms (2)

Integrated intervention

EXPERIMENTAL

Integrated intervention of smoking cessation and breastfeeding

Behavioral: Integrated intervention of smoking cessation and breastfeeding

Attention placebo control group

ACTIVE COMPARATOR

Instructions on general pregnancy and infant care

Behavioral: Attention placebo control

Interventions

The intervention group will receive an integrated intervention of smoking cessation and breastfeeding: education and counseling, monitoring and feedback, and contingent financial incentives.

Integrated intervention

Participants in the control group will receive usual prenatal care from physicians, nurses, or social workers. They will receive best standard care on smoking cessation and breastfeeding, including referral to the New York State Smokers' Quitline and the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC).

Attention placebo control group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be 18 years or older
  • At ≤28 weeks of pregnancy
  • Daily smoking cigarettes and/or cigars in the past 7 days
  • Be able to read, listen, and talk in English

You may not qualify if:

  • Being diagnosed with cancer
  • Current heavy drinking (more than 2 drinks a day)
  • Current use of illicit substances
  • Medical conditions contraindicating breastfeeding such as HIV infection, active tuberculosis, and breast removal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Division of Behavioral Medicine Department of Pediatrics Jacobs School of Medicine and Biomedical Sciences State University of New York at Buffalo

Buffalo, New York, 14214, United States

Location

MeSH Terms

Conditions

Cigarette SmokingBreast Feeding

Interventions

Lactation

Condition Hierarchy (Ancestors)

Tobacco SmokingSmokingBehaviorTobacco UseFeeding Behavior

Intervention Hierarchy (Ancestors)

Reproductive Physiological PhenomenaReproductive and Urinary Physiological PhenomenaPostpartum Period

Results Point of Contact

Title
Dr. Xiaozhong Wen
Organization
State University of New York at Buffalo

Study Officials

  • Xiaozhong Wen, MD, PhD

    State University of New York at Buffalo

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Research staff who collect and analyze outcome data will be blinded to participants' group assignments.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The 40 eligible participants will be randomized into either the intervention (N=20) or control group (N=20). A sequence of random numbers in blocks of 2 will be used to ensure equal numbers of participants for each group over time.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 26, 2021

First Posted

November 17, 2021

Study Start

January 1, 2021

Primary Completion

October 30, 2023

Study Completion

October 30, 2023

Last Updated

April 17, 2025

Results First Posted

April 17, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations